Digestive Disease Research Center Digestive Disease Research Center Digestive Disease Research Center

Research Focus Area
Recent Publications

Sherkat R, Rostami S, Yaran M, Emami MH, Saneian H, Tavakoli H, Adibi P, Behnam M, Sheykhbahaei S, Bagherpour B, Khoshnevisan R. Establishment and development of the first biobank of inflammatory bowel disease, suspected to primary immunodeficiency diseases in Iran. Advanced biomedical research. 2018;7.

Abstract :

Inflammatory bowel disease (IBD) might be an immunodeficiency rather than an excessive inflammatory reaction. IBD, suspected to primary immunodeficiency diseases biobank (IBDSPIDB) as a resource for researches can help improve the prevention, diagnosis, and illness treatment and the health promotion throughout the society. Therefore, we launched the biobank of IBDSPID for the first time in Iran.

Rahimi H, hasan Emami M, Fayyazi E, Mirdamadi NS, Gharahkhani R, Mirmosayyeb O, Fahim A, Poorbafrani M, Serati M, Tavakol N. Comparing the Effect of Aripiprazole with Nortriptyline on Severity of Irritable Bowel Syndrome. Govaresh. 2019 Jan 1;23(4):257-64.

Abstract :

Neuropsychiatric factors play important roles in symptoms of irritable bowel syndrome (IBS). Mood disorders such as bipolar disorder are prevalent among patients with IBS. Antidepressants are used traditionally for management of IBS symptoms but antibipolar agents have not been studied. Aripiprazole, an antibipolar agent, was selected because of having the least anticholinergic side effects. 

Events and News

View More

All rights reserved by Poursina Halkim poursinahakim.com